Skip to Content
Merck
  • Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.

Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.

Journal of medicinal chemistry (2010-01-15)
Manthena V S Varma, R Scott Obach, Charles Rotter, Howard R Miller, George Chang, Stefanus J Steyn, Ayman El-Kattan, Matthew D Troutman
ABSTRACT

Oral bioavailability (F) is a product of fraction absorbed (Fa), fraction escaping gut-wall elimination (Fg), and fraction escaping hepatic elimination (Fh). In this study, using a database comprised of Fa, Fg, Fh, and F values for 309 drugs in humans, an analysis of the interrelation of physicochemical properties and the individual parameters was carried out in order to define the physicochemical space for optimum human oral bioavailability. Trend analysis clearly indicated molecular weight (MW), ionization state, lipophilicity, polar descriptors, and free rotatable bonds (RB) influence bioavailability. These trends were due to a combination of effects of the properties on Fa and first-pass elimination (Fg and Fh). Higher MW significantly impacted Fa, while Fg and Fh decreased with increasing lipophilicity. Parabolic trends were observed for bioavailability with polar descriptors. Interestingly, RB has a negative effect on all three parameters, leading to its pronounced effect on bioavailability. In conclusion, physicochemical properties influence bioavailability with typically opposing effects on Fa and first-pass elimination. This analysis may provide a rational judgment on the physicochemical space to optimize oral bioavailability.

MATERIALS
Product Number
Brand
Product Description

Supelco
Cyclosporin A, VETRANAL®, analytical standard
Sigma-Aldrich
Ibuprofen, meets USP testing specifications
Sigma-Aldrich
Erythromycin, meets USP testing specifications
Supelco
(−)-Nicotine solution, 1.0 mg/mL, analytical standard, for drug analysis
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Supelco
Warfarin, analytical standard
Sigma-Aldrich
Rifampicin, ≥95% (HPLC), powder or crystals
Sigma-Aldrich
Rifampicin, suitable for plant cell culture, BioReagent, ≥95% (HPLC), powder or crystals
Sigma-Aldrich
Mevinolin from Aspergillus sp., ≥98% (HPLC)
Sigma-Aldrich
Trimethoprim, ≥98.5%
Sigma-Aldrich
Tetracycline, 98.0-102.0% (HPLC)
Supelco
(−)-Cotinine solution, drug standard, 1.0 mg/mL in methanol
Supelco
(−)-Nicotine, PESTANAL®, analytical standard
Sigma-Aldrich
Cyclosporin A, BioReagent, from Tolypocladium inflatum, Molecular Biology, ≥95%
Supelco
Caffeine solution, analytical standard, 1.0 mg/mL in methanol
Sigma-Aldrich
Erythromycin, tested according to Ph. Eur.
Supelco
Mebendazole, VETRANAL®, analytical standard
Sigma-Aldrich
Cyclosporin A, 97.0-101.5% (on dried basis)
Supelco
Trimethoprim, VETRANAL®, analytical standard
Sigma-Aldrich
Trimethoprim, ≥99.0% (HPLC)
Supelco
Prednisolone, VETRANAL®, analytical standard
Sigma-Aldrich
Theophylline, anhydrous, ≥99%, powder
Supelco
Ibuprofen
Sigma-Aldrich
Indomethacin, 98.0-102.0%, meets EP testing specifications
Sigma-Aldrich
Ibuprofen, ≥98% (GC)
Sigma-Aldrich
Erythromycin, potency: ≥850 μg per mg
Supelco
Mebendazole, analytical standard, ≥98% (HPLC)
Supelco
Melting point standard 235-237°C, analytical standard
Supelco
Warfarin, PESTANAL®, analytical standard
Sigma-Aldrich
2-Propylpentanoic acid